Header

UZH-Logo

Maintenance Infos

Update in the mechanisms of allergen-specific immunotheraphy


Akkoc, T; Akdis, M; Akdis, C A (2011). Update in the mechanisms of allergen-specific immunotheraphy. Allergy, Asthma & Immunology Research, 3(1):11-20.

Abstract

Allergic diseases represent a complex innate and adoptive immune response to natural environmental allergens with Th2-type T cells and allergen-specific IgE predominance. Allergen-specific immunotherapy is the most effective therapeutic approach for disregulated immune response towards allergens by enhancing immune tolerance mechanisms. The main aim of immunotherapy is the generation of allergen nonresponsive or tolerant T cells in sensitized patients and downregulation of predominant T cell- and IgE-mediated immune responses. During allergen-specific immunotherapy, T regulatory cells are generated, which secrete IL-10 and induce allergen-specific B cells for the production of IgG4 antibodies. These mechanisms induce tolerance to antigens that reduces allergic symptoms. Although current knowledge highlights the role of T regulatory cell-mediated immunetolerance, definite mechanisms that lead to a successful clinical outcomes of allergen-specific immunotherapy still remains an open area of research.

Abstract

Allergic diseases represent a complex innate and adoptive immune response to natural environmental allergens with Th2-type T cells and allergen-specific IgE predominance. Allergen-specific immunotherapy is the most effective therapeutic approach for disregulated immune response towards allergens by enhancing immune tolerance mechanisms. The main aim of immunotherapy is the generation of allergen nonresponsive or tolerant T cells in sensitized patients and downregulation of predominant T cell- and IgE-mediated immune responses. During allergen-specific immunotherapy, T regulatory cells are generated, which secrete IL-10 and induce allergen-specific B cells for the production of IgG4 antibodies. These mechanisms induce tolerance to antigens that reduces allergic symptoms. Although current knowledge highlights the role of T regulatory cell-mediated immunetolerance, definite mechanisms that lead to a successful clinical outcomes of allergen-specific immunotherapy still remains an open area of research.

Statistics

Citations

Dimensions.ai Metrics
33 citations in Web of Science®
40 citations in Scopus®
67 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

187 downloads since deposited on 08 Mar 2011
9 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, not_refereed, original work
Communities & Collections:04 Faculty of Medicine > Swiss Institute of Allergy and Asthma Research
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2011
Deposited On:08 Mar 2011 15:22
Last Modified:17 Feb 2018 13:18
Publisher:The Korean Academy of Asthma Allergy and Clinical Immunology
ISSN:2092-7355
OA Status:Hybrid
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.4168/aair.2011.3.1.11
PubMed ID:21217920

Download

Download PDF  'Update in the mechanisms of allergen-specific immunotheraphy'.
Preview
Filetype: PDF
Size: 1MB
View at publisher